- Molecular mechanisms in temozolomide-resistant glioblastoma
Sang Y. Lee et al, 2021, Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies CrossRef - Differential regulation of the pro-inflammatory biomarker, YKL-40/CHI3L1, by PTEN/Phosphoinositide 3-kinase and JAK2/STAT3 pathways in glioblastoma
Yubing Wang et al, 2018, Cancer Letters CrossRef - TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells
Sandra Pinet et al, 2016, Oncotarget CrossRef - Influence of YKL‑40 gene RNA interference on the biological behaviors of endometrial cancer HEC‑1A cells
Lili Li et al, 2018, Oncology Letters CrossRef - The E3 Ubiquitin Ligase NEDD4-1 Mediates Temozolomide-Resistant Glioblastoma through PTEN Attenuation and Redox Imbalance in Nrf2–HO-1 Axis
Hao-Yu Chuang et al, 2021, International Journal of Molecular Sciences CrossRef - Functional analysis of the short splicing variant encoded by CHI3L1/YKL-40 in glioblastoma
Mengqi Shi et al, 2022, Frontiers in Oncology CrossRef - CHI3L1 predicted in malignant entities is associated with glioblastoma immune microenvironment
Fei Li et al, 2022, Clinical Immunology CrossRef - Knockdown of YKL‐40 inhibits angiogenesis through regulation of VEGF/VEGFR2 and ERK1/2 signaling in endometrial cancer
Hong‐Yan Chen et al, 2021, Cell Biology International CrossRef - Bioactive triterpenoid saponins and phenolic compounds against glioma cells
Xuewei Ye et al, 2014, Bioorganic & Medicinal Chemistry Letters CrossRef - Hi-LASSO: High-Dimensional LASSO
Youngsoon Kim et al, 2019, IEEE Access CrossRef - MAPK8 mediates resistance to temozolomide and apoptosis of glioblastoma cells through MAPK signaling pathway
Peng Xu et al, 2018, Biomedicine & Pharmacotherapy CrossRef - High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder
Ying-En Lee et al, 2019, Urologic Oncology: Seminars and Original Investigations CrossRef - CHI3L1, NTRK2, 1p/19q and IDH Status Predicts Prognosis in Glioma
Elise Deluche et al, 2019, Cancers CrossRef - Mesenchymal/radioresistant traits in granular astrocytomas: evidence from a combined clinical and molecular approach
Rebecca Senetta et al, 2016, Histopathology CrossRef - High VEGFA Expression Is Associated with Improved Progression-Free Survival after Bevacizumab Treatment in Recurrent Glioblastoma
Bárbara Alves et al, 2023, Cancers CrossRef - The anti-tumor activity of the STAT3 inhibitor STX-0119 occurs via promotion of tumor-infiltrating lymphocyte accumulation in temozolomide-resistant glioblastoma cell line
Yasuto Akiyama et al, 2017, Immunology Letters CrossRef - Chitinase-3 like-protein-1 function and its role in diseases
Ting Zhao et al, 2020, Signal Transduction and Targeted Therapy CrossRef - The Evaluation of AREG, MMP-2, CHI3L1, GFAP, and OPN Serum Combined Value in Astrocytic Glioma Patients’ Diagnosis and Prognosis
Rūta Urbanavičiūtė et al, 2020, Brain Sciences CrossRef - Role of chitinase-like proteins in cancer
Julia Kzhyshkowska et al, 2016, Biological Chemistry CrossRef - Enhancing Transcriptional Reprogramming of Mesenchymal Glioblastoma with Grainyhead-like 2 and HDAC Inhibitors Leads to Apoptosis and Cell-Cycle Dysregulation
Spandana Kotian et al, 2023, Genes CrossRef - Prognostic Value of YKL-40 in Patients with Glioblastoma: a Systematic Review and Meta-analysis
Gang Qin et al, 2017, Molecular Neurobiology CrossRef - Interleukin-13 receptor alpha 2 cooperates with EGFRvIII signaling to promote glioblastoma multiforme
Jennifer P. Newman et al, 2017, Nature Communications CrossRef - Targeted Therapy for Malignant Brain Tumors
Paula Lam et al, 2016, Redox-Active Therapeutics CrossRef - Serum YKL-40 Level Positively Correlates With Uterine Leiomyomas
Wenping Guo et al, 2016, Reproductive Sciences CrossRef - Frequent variations in cancer-related genes may play prognostic role in treatment of patients with chronic myeloid leukemia
Alexander V. Lavrov et al, 2016, BMC Genetics CrossRef - Exploring the potentials of S4, a selective androgen receptor modulator, in glioblastoma multiforme therapy
Mervenur Yavuz et al, 2024, Toxicology and Applied Pharmacology CrossRef